corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13085

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Wang SS.
Jury Orders Payment From Wyeth, Upjohn Of Over $27 Million
The Wall Street Journal 2008 Mar 7
http://online.wsj.com/article/SB120484350530317759.html?mod=yahoo_hs&ru=yahoo


Full text:

Wyeth and Upjohn Co. were ordered to pay more than $27 million in punitive damages to an Arkansas woman after a federal jury concluded she developed breast cancer from taking the firms’ hormone-replacement therapies.

The jury last week awarded $2.7 million in compensatory damages after finding the firms hadn’t adequately warned Donna Scroggin that the drugs carried an increased risk of breast cancer. Yesterday, it said Wyeth should pay $19.4 million and Upjohn, a Pfizer Inc. unit, should pay $7.8 million.

A Wyeth spokesman said the firm will explore post-trial options, appealing if necessary. Pfizer’s associate general counsel said the firm complied with all labeling requirements.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963